Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 Study of Roxadustat for Treatment of Anemia in Non-Dialysis Chronic Kidney Disease
2012-005180-27Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in anemia of renal disease comparing roxadustat with placebo (2 arms). Primary endpoint: Hemoglobin response. Started Dec 2012; status: completed.
02
Drugs
roxadustat
03
Conditions
anemia of renal disease
Beyond the preview
Go deeper on 2012-005180-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005180-27.